Smith & Nephew to extend arthroscopic offerings with purchase of Acufex for $141 mil..
This article was originally published in The Gray Sheet
Executive SummarySMITH & NEPHEW EXPANDING ARTHROSCOPIC BUSINESS WITH $141 MIL. ACUFEX PURCHASE from American Home Products. Smith & Nephew says that Acufex's product line, including hand-held arthroscopic surgical instruments, soft tissue fixation devices and drill guide systems, would complement the line of arthroscopic video cameras and powered surgical instruments manufactured by Smith & Nephew's Dyonics unit. Acufex's arthroscopic fixation devices include a bioabsorbable, staple-like button and a titanium-based fixation device, both of which are used in ligament repair.
You may also be interested in...
Sandoz CEO Richard Saynor has pledged that the company will ensure stable pricing for essential coronavirus-related medicines amid concerns over how the outbreak will affect the supply chain.
Executives On The Move: Comings And Goings At Atara Biothera And Pfizer, Along With A Promotion At Domainex
T-cell immunotherapy firm Atara Biotherapeutics decides on a chief commercial officer and Pfizer oncology R&D head leaves for CSO spot at Vividion Therapeutics. Also, COO of UK drug discovery CRO Domainex is set to climb to CEO position.
The World Trade Organization is not the place to discuss pharmaceutical pricing, and strong intellectual property rights do not threaten access to medicines, according to EU and US delegations to the WTO.